Z-0468-2022 Class I Ongoing
FDA device recall Z-0468-2022 was initiated by Getinge Usa Sales Inc on Dec 9, 2021 and is designated Class I. Reason for recall: A potential chemical degradation of Sevoflurane by Lewis acids (metal oxides and metal halides) has been discovered that may result in inhalation and/or skin exposure of hydrogen fluoride. The recall status is ongoing. Affected quantity: 50 US; 898 OUS.
Recall details
- Product Type
- Devices
- Report Date
- Jan 19, 2022
- Initiation Date
- Dec 9, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 50 US; 898 OUS
Product description
Reason for recall
Distribution pattern
Worldwide distribution - US Nationwide distribution in the states of VA and MO. The countries of Austria, Bahrain, Bolivia, Brazil, Bulgaria, Chile, China, Colombia, Estonia, Iraq, Israel, Italy, Japan, Kenya, Malaysia, Mexico, Morocco, Nicaragua, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Portugal, Saudi Arabia, Singapore, South Africa, Thailand, Trinidad and Tobago, Tunisia, Turkey, United Arab Emirates, United Kingdom, and Vietnam.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0468-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026